Encompass Health (EHC) Stock Price, News & Analysis

Company Overview

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states. Headquartered in Birmingham, Alabama, Encompass Health has built a reputation for integrating clinical expertise with data‐driven care models, collaborating with referring physicians, hospitals and payers to optimize patient outcomes and manage overall costs. Its multidisciplinary approach emphasizes early discharge planning, community reintegration and ongoing continuity of care.

Under the leadership of President and Chief Executive Officer Mark Tarr and Chief Financial Officer William Wellman, Encompass Health continues to invest in facility expansion, telehealth initiatives and digital health platforms to enhance care coordination and patient engagement. The company’s strategic priorities include strengthening partnerships with acute‐care providers, expanding its home health footprint and leveraging clinical analytics to streamline operations and improve quality metrics. With a focus on innovation and evidence‐based practices, Encompass Health aims to address the growing demand for rehabilitation and home‐based services driven by an aging population and evolving payment models.

Key Stats

• Today's Range: $121.06 to $123.15
• 50-Day Range: $99.22 to $125.78
• 52-Week Range: $92.77 to $127.99
• Volume: 56,974 shs
• Average Volume: 1.06 million shs
• Market Capitalization: $12.03 billion
• P/E Ratio: 19.87
• Dividend Yield: 0.62%
• Price Target: $148.71
• Consensus Rating: Buy

Encompass Health Stock Analysis - MarketRank™

Encompass Health scored higher than 98% of companies evaluated by MarketBeat, and ranked 9th out of 914 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Buy

Consensus Rating

Encompass Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 7 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Encompass Health has a consensus price target of $148.71, representing about 22.9% upside from its current price of $121.05.

Amount of Analyst Coverage

Encompass Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.55%

Earnings Growth

Earnings for Encompass Health are expected to grow by 8.55% in the coming year, from $6.08 to $6.60 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Encompass Health is 19.72, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Encompass Health is 19.72, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.68.

Price to Earnings Growth Ratio

Encompass Health has a PEG Ratio of 2.47. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Encompass Health has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.38% of the float of Encompass Health has been sold short.

Short Interest Ratio / Days to Cover

Encompass Health has a short interest ratio ("days to cover") of 2.83, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Encompass Health has recently decreased by 10.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Encompass Health has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Encompass Health has only been increasing its dividend for 2 years.

Dividend Coverage

The dividend payout ratio of Encompass Health is 12.38%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Encompass Health will have a dividend payout ratio of 11.52% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 1.13

News Sentiment

Encompass Health has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Encompass Health this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

MarketBeat Follows

3 people have added Encompass Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Encompass Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,434,845.00 in company stock.

Percentage Held by Insiders

1.80% of the stock of Encompass Health is held by insiders.

Percentage Held by Institutions

97.25% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 7/15 Dividend: 7/01/2026
• Ex-Dividend for 7/15 Dividend: 7/01/2026
• Dividend Payable: 7/15/2026
• Last Earnings: 8/05/2026
• Today: 9/03/2026
• Record date for 10/15 Dividend: 10/01/2026
• Ex-Dividend for 10/15 Dividend: 10/01/2026
• Dividend Payable: 10/15/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:EHC
• CIK: 785161
• Web: www.healthsouth.com
• Phone: (205) 967-7116
• Fax: 205-969-4719
• Employees: 42,000
• Year Founded: 1984

Price Target and Rating

• Average Price Target for Encompass Health: $148.71
• High Price Target: $160.00
• Low Price Target: $140.00
• Potential Upside/Downside: +21.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.14
• Trailing P/E Ratio: 19.92
• Forward P/E Ratio: 20.09
• P/E Growth: 2.47
• Net Income: $566.20 million
• Net Margins: 10.01%
• Pretax Margin: 16.56%
• Return on Equity: 18.08%
• Return on Assets: 8.22%

Debt

• Debt-to-Equity Ratio: 0.76
• Current Ratio: 1.19
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $5.94 billion
• Price / Sales: 2.03
• Cash Flow: $8.89 per share
• Price / Cash Flow: 13.73
• Book Value: $34.50 per share
• Price / Book: 3.54

Miscellaneous

• Outstanding Shares: 98,650,000
• Free Float: 96,877,000
• Market Cap: $12.05 billion
• Optionable: Optionable
• Beta: 0.75